Canada markets open in 8 hours 36 minutes

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
8.59+0.08 (+0.94%)
At close: 03:59PM EDT
Full screen
Previous Close8.51
Open8.55
Bid8.42 x 0
Ask8.63 x 0
Day's Range8.41 - 8.66
52 Week Range7.03 - 9.26
Volume22,134
Avg. Volume4,925
Market Cap99.749M
Beta (5Y Monthly)0.93
PE Ratio (TTM)16.21
EPS (TTM)0.53
Earnings DateMay 24, 2024 - May 28, 2024
Forward Dividend & Yield0.18 (2.10%)
Ex-Dividend DateFeb 28, 2024
1y Target Est9.00
  • GlobeNewswire

    BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023

    MISSISSAUGA, Ontario, March 13, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2023. Key highlights include: (CAD)Q4 2023% Change vs. Q4 2022FY 2023% Change vs. FY 2022Canadian Pharma Sales7,989,09810%29,554,89913%International Pharma Sales54,750-54%1,047,74753%Total Company Sales8,273,68611%31,590,30213%EBITDA11,650,3015%7,926,4787%Net Income After Taxes (NIAT)1,450,79121

  • GlobeNewswire

    BioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024

    MISSISSAUGA, Ontario, March 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2023 on Wednesday, March 13th after market hours. A presentation on the Company’s fourth quarter and full year 2023 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exc

  • Simply Wall St.

    Why You Might Be Interested In BioSyent Inc. (CVE:RX) For Its Upcoming Dividend

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BioSyent Inc...